Comparing Tocilizumab Biosimilar BAT1806/BIIB800 with Reference Tocilizumab in Patients with Moderate-to-severe Rheumatoid Arthritis with an Inadequate Response to Methotrexate: a Phase 3, Randomised, Multicentre, Double-Blind, Active-Controlled Clinical Trial